Organic compounds -- part of the class 532-570 series – Organic compounds – Halogen containing
Patent
1992-02-18
1994-02-01
Lone, Werren B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Halogen containing
514744, 570238, C07C 2102, C07C 2114, A01N 2902, A61K 31035
Patent
active
052833836
ABSTRACT:
The present invention relates to a new antitumor compound, a method for isolating same from a red alga, antitumor compositions containing same and methods of using same for treating patients with cancer. The compound of the present invention is 6(R)-bromo-3(S)-bromomethyl-7-methyl-2,3,7-trichloro-1-octene.
REFERENCES:
patent: 3564101 (1971-02-01), Regan
patent: 3671655 (1972-06-01), Regan
Boyd, Michael R., Principles and Practice of Oncology Updates, ed. DeVita, Hellman & Rosenberg, vol. 3, #10, 1-12, 1989.
Burreson et al., Chemistry Letters 1111-1114, 1975.
Collins, Jerry M., Cancer Chemotherapy: Principles and Practice by Chabner and Collins, Chapter 2, J. B. Lippincott, Philadelphia, 1990.
Boyd et al., "Data Display and Analysis Strategies for the NCI Disease-Oriented In Vitro Antitumor Drug Screen", in Anticancer Drug Discovery and Development, eds Valerlote, F. A., Corbett, T. Baker, L.; Kluwer Academic Publishers, Amsterdam (in press 1990).
Monks et al., J. National Cancer Institute 83, No. 11, 757-766, 1991.
Boyd, Michael R. "The Future of Drug Development", in Current Therapy in Oncology; Section I. Introduction to Cancer Therapy; Chapter 2; ed Niederhuber; B. C. Decker, Inc., Philadelphia, (in press 1991).
Boyd Michael R.
Cardellina, II John H.
Clardy Jon
Fuller Richard W.
Snader Kenneth M.
Lone Werren B.
The United States of America as represented by the Department of
LandOfFree
Antitumor compound, compositions and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumor compound, compositions and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor compound, compositions and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581033